Scientists trying to create drugs to treat chronic inflammation in diseases like arthritis now have a new culprit known as MMP2. New University of British Columbia research shows that this enzyme works as a master switch to activate inflammatory diseases.
Jan 22, 2013
An information source that gives journalists access to UBC’s expertise.
